Follow the OXURION share price and the full directors' dealings record of the company, a listed equity based in Belgium. Shares are listed on the BE market, under the authority of FSMA. Market capitalisation: €366k. The latest transaction was reported on 10 March 2022 (Purchase). Among the most active insiders: Bareldam SA. All data is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€3m
2 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Buys €3mn/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,766,337 shares@ €2.03100.0% of flowShareOff exchangeISINISIN BE0003846632FSMA:oxurion-0
3 of 3 declarations
About OXURION
OXURION is a Belgian biopharmaceutical company focused on developing treatments for eye diseases. It aims to provide innovative therapies to improve patients' vision.